Bleeding Disorders
Conference Coverage
Solulin variants activate TAFI in vitro
A new generation of solulin variants is showing promise in the treatment of severe hemophilia A.
Conference Coverage
Boys with severe hemophilia have good physical function
Children with severe hemophilia have generally good self-reported health-related quality of life and physical functioning, but one issue in...
Conference Coverage
ITI protects against bleeding in hemophilia A with factor VIII inhibitors
Immune tolerance induction in hemophilia A patients with inhibitor development against FVIII may provide some protection against bleeding.
Conference Coverage
Study: No link between vaccines, inhibitor development
Pediatric vaccinations given near the time of factor VIII exposure are not linked with inhibitor development in patients with severe hemophilia A...
Conference Coverage
AHEAD studies establish bleed rate benchmarks
More than 37% of patients who had moderate or severe hemophilia A and were on prophylaxis experienced less than one bleed per year on average, and...
From the Journals
Sickle cell trait artificially lowers HbA1c
HbA1c levels systematically underestimate glucose levels in black patients who carry the sickle cell trait, researchers say.
From the Journals
Ruxolitinib beats best available care for hematocrit control in polycythemia
Ruxolitinib was superior to best available care for hematocrit control among patients with polycythemia vera without splenomegaly.
News
Drug granted fast track designation for PNH
The US Food and Drug Administration (FDA) has granted fast track designation for the complement C3 inhibitor APL-2. The designation applies to...
Conference Coverage
VIDEO: Point-of-care microsensor prototype beats conventional coagulopathy tests
Using less than a drop of blood, a portable microsensor provided a comprehensive coagulation profile in minutes
Conference Coverage
Microsensor perfectly distinguished coagulopathy patients from controls
SAN DIEGO – A portable microsensor provided a comprehensive coagulation profile in less than 15 minutes and perfectly distinguished various...
Conference Coverage
VIDEO: Artificial blood cells clear first phase of animal testing
SAN DIEGO - An artificial red blood cell has come close to emulating the key functions of natural cells.